B-cell development

Last updated: November 01, 2022

B-cell development

Adv. P/P II

Adv. P/P II

Prader-Willi syndrome
Angelman syndrome
Fragile X syndrome
Beckwith-Wiedemann syndrome
Turner syndrome
Klinefelter syndrome
Cri du chat syndrome
Cystic fibrosis
Phenylketonuria (NORD)
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Familial hypercholesterolemia
Spinal muscular atrophy
Wiskott-Aldrich syndrome
Tay-Sachs disease (NORD)
Marfan syndrome
Systemic lupus erythematosus
Graves disease
Hashimoto thyroiditis
Rheumatoid arthritis
HIV (AIDS)
Epstein-Barr virus (Infectious mononucleosis)
Cytomegalovirus
Cytokines
Introduction to the immune system
Cytokines
Innate immune system
Complement system
T-cell development
B-cell development
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Vaccinations
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Crohn disease
Colorectal cancer
Ulcerative colitis
Irritable bowel syndrome
Peptic ulcer
Clostridium difficile (Pseudomembranous colitis)
Diverticulosis and diverticulitis
Wilson disease
Gastroesophageal reflux disease (GERD)
Hirschsprung disease
Pyloric stenosis
Cleft lip and palate
Enteric nervous system
Esophageal motility
Carbohydrates and sugars
Proteins
Fats and lipids
Cushing syndrome
Primary adrenal insufficiency
Diabetes mellitus
Diabetic nephropathy
Diabetic retinopathy
Eating disorders: Pathology review
Bulimia nervosa
Anorexia nervosa
Kidney stones
Lower urinary tract infection
Acute pyelonephritis
Chronic pyelonephritis
Poststreptococcal glomerulonephritis
Membranoproliferative glomerulonephritis
Acute kidney injury: Clinical
Chronic kidney disease
Nephroblastoma (Wilms tumor)
Renal system anatomy and physiology
Glomerular filtration
Regulation of renal blood flow
Renal azotemia
Prerenal azotemia
Postrenal azotemia
Focal segmental glomerulosclerosis (NORD)
Membranous nephropathy
Rapidly progressive glomerulonephritis
IgA nephropathy (NORD)
Minimal change disease
Hydronephrosis
Lupus nephritis
Delayed puberty
Precocious puberty
Polycystic ovary syndrome
Menopause
Premenstrual dysphoric disorder
Urethritis
Priapism
Varicocele
Testicular and scrotal conditions: Pathology review
Cryptorchidism
Orchitis
Epididymitis
Prostatitis
Testicular torsion
Benign prostatic hyperplasia
Pelvic inflammatory disease
Gardnerella vaginalis (Bacterial vaginosis)
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
Human papillomavirus
Treponema pallidum (Syphilis)
Neisseria gonorrhoeae
Herpes simplex virus
Poxvirus (Smallpox and Molluscum contagiosum)
Pediculus humanus and Phthirus pubis (Lice)
Uterine disorders: Pathology review
Amenorrhea
Osteoarthritis
Osteoporosis
Bone disorders: Pathology review
Ankylosing spondylitis
Gout
Gout and pseudogout: Pathology review
Fibromyalgia
Myalgias and myositis: Pathology review
Polymyositis
Dermatomyositis
Inclusion body myopathy
Rhabdomyosarcoma
Osteomalacia and rickets
Paget disease of bone
Osteomyelitis
Osgood-Schlatter disease (traction apophysitis)
Atopic dermatitis
Contact dermatitis
Psoriasis
Pityriasis rosea
Lichen planus
Hidradenitis suppurativa
Rosacea
Bullous pemphigoid
Vesiculobullous and desquamating skin disorders: Pathology review
Varicella zoster virus
Urticaria
Scleroderma
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Hyperthyroidism
Thyroid storm
Hypothyroidism
Hyperprolactinemia
Prolactinoma
Gigantism
Acromegaly
Hypopituitarism
Adrenal insufficiency: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes insipidus and SIADH: Pathology review
Burns
Skin cancer: Pathology review
Skin cancer
Mitosis and meiosis
Cell cycle

Transcript

Watch video only

Your immune system is like the military - with two main branches, the innate immune response and the adaptive immune response.

The innate immune response is immediate and non-specific, meaning that although it can distinguish an invader from a human cell, it doesn’t distinguish one invader from another invader.

In contrast, the adaptive immune response is highly specific for each invader, and that’s because the cells of the adaptive immune response have receptors that differentiate friendly bacteria and potentially deadly ones from their unique parts - called antigens.

This adaptive immune response takes days to weeks to become activated, but is also responsible for immunologic memory.

Now, the key cells of the adaptive immune response are the lymphocytes- the B and T cells -which are generated during lymphopoiesis.

Lymphopoiesis has three goals - first, to generate a diverse set of lymphocytes - each with a unique antigen receptor, second, to get rid of lymphocytes that have receptors that are self-reactive meaning that they’ll bind to healthy tissue, and third, to allow lymphocytes that aren’t self-reactive to continue maturing in secondary lymphoid tissue.

Normally, hematopoietic stem cells, within the bone marrow mature into a common lymphoid progenitor cell, which then becomes either a B-cell or a T-cell.

To become a B cell, it has to develop into an immature B-cell in the bone marrow and then complete its maturation into an antibody secreting B cell, called a plasma cell, in the lymph nodes and spleen.

To become a T cell, it has to migrate to the thymus and become a thymocyte, where it completes its development into a mature T cell.

So, “B” for bone marrow and “T” for thymus.

Throughout B cell development, the developing cells are interacting closely with the stromal cells of the bone marrow, which are largely composed of mesenchymal stem cells.

Mesenchymal cells are multipotent and can differentiate into various cells including macrophages and endothelial cells.

Mesenchymal cells provide B cell with adhesion molecules they can use to attach and important growth factors like interleukin 7, they can use to grow and proliferate.

As they develop, B cells go through 6 stages: They start as common lymphoid progenitor cells, then become early pro-B cells, then late pro-B cells, then large pre-b cells, then small pre-B cells, and finally immature B cells.

As the cell develops it makes permanent changes in its DNA so that by the time it’s an immature B cell it has DNA that uniquely codes for a B cell receptor that can bind to foreign antigens but isn’t self-reactive.

The B cell receptor has two chains, a heavy chain and a light chain.

The heavy chain contains regions that determine the type of antibody it will become as well as whether the B cell receptor will be surface bound or secreted, like an antibody.

The region where the heavy chain and light chain come together form a unique protein structure capable of binding proteins, carbohydrates, or lipids that the B cell might eventually encounter - and this is called the antigen binding site.

The antigen binding site of the B cell receptor is made up of three protein segments that are called V for variable, D for diversity, and J for joining.

The heavy chain is made up of 1 V segment, 1 D segment, and 1 J segment; while the light chain only contains a V and J segment - this is easy to remember - just think of it as the extra segment making the heavy chain heavier.

Every person inherits multiple genes that encode the V, D, and J protein segments, and these segments can be mixed and matched to make a unique structure.

A bit like how you might have several pairs of shoes, pants, and shirts and can mix and match them to create lots of different outfit combinations.

For the heavy chain, each person has 44 V gene segments, 27 D segments, and 6 J segments! And there are even more V and J segments for the light chain.

So one B cell might have a B cell receptor with a heavy chain that has a VH1-DH3-JH5 combination and a light chain that’s VL7-JL2, and another B cell might have a B cell receptor with a heavy chain that has a VH44-DH10-JH1 combination and a light chain that’s VL2-JL3.

And that would mean that these two B-cells would have completely different B cell receptors and therefore different antigen specificities.

Now, to have a fully functioning B cell receptor, a B cell has to get through a series of successful gene rearrangements, first for the heavy chain and then the light chain. And if the B cell fails at any stage, it dies!

It all starts with a common lymphoid progenitor cell which has various V, D, and J gene segments all lined up in its germline DNA.

Two enzymes, Rag-1 and Rag-2, start getting expressed, and that signifies that the cell is now an early pro-B cell.

Rag-1 and Rag-2 help to splice together D and J segments on both chromosomes, and the chromosome that successfully rearranges first will then suppress the other chromosome from rearranging - a process called allelic exclusion.

If a cell successfully joins a D segment to a J segment, then it’s considered a late pro-B cell.

Next, the late pro-B cell has to attach its D-J gene segment to a V gene segment, with the help of an additional enzyme called V(D)J recombinase.

Once the VDJ segment are combined, the full heavy chain’s antigen binding site is complete and needs to be recombined with the mu gene, which codes for the constant region of the antibody. T

he mu gene codes for the protein that makes the IgM constant region and it’s the first of the different types of antibody constant regions that are expressed on B cells.

Key Takeaways

B-cell development consists of a series of cellular transitions, from hematopoietic stem cells into immunocompetent B cells. Depending on the step, these processes take place in different organs namely the bone marrow, lymph nodes, and spleen.

Like any other type of blood cell, B cells originate from hematopoietic stem cells (HSCs). HSCs give rise to common lymphoid progenitor cells, which in their turn become either B-cells or T-cells. B cell development takes place in a series of six main stages. First, they start as common lymphoid progenitor cells, which become early pro-B cells, then late pro-B cells, next large pre-B cells, then small pre-B cells, and finally, immature B cells. Immature B cells then migrate from the bone marrow into the lymph nodes and spleen to complete the process of maturation.